Abbott Labs Cutting 1900 Jobs As Restructuring the The Drug Division Takes Place In addition one glucose monitor was discontinued, so again looking at what perhaps is profitable and where work is needed in both areas, this could be a good thing and it wouldn???t surprise me to see a biotech incubator come along here as well to help the small biotech companies, others such as J and J are already se